5-amino-5'-fluoro-8-nitro-2'-oxo-2,3-dihydro-1H-spiro[imidazo[1,2-a]pyridine-7,3'-indoline]-6-carbonitrile

ID: ALA3763609

Chembl Id: CHEMBL3763609

PubChem CID: 127037869

Max Phase: Preclinical

Molecular Formula: C15H11FN6O3

Molecular Weight: 342.29

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CC1=C(N)N2CCNC2=C([N+](=O)[O-])C12C(=O)Nc1ccc(F)cc12

Standard InChI:  InChI=1S/C15H11FN6O3/c16-7-1-2-10-8(5-7)15(14(23)20-10)9(6-17)12(18)21-4-3-19-13(21)11(15)22(24)25/h1-2,5,19H,3-4,18H2,(H,20,23)

Standard InChI Key:  MGUINACFKDKBAG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3763609

    ---

Associated Targets(Human)

BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 342.29Molecular Weight (Monoisotopic): 342.0877AlogP: 0.07#Rotatable Bonds: 1
Polar Surface Area: 137.32Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.75CX Basic pKa: 0.18CX LogP: 0.13CX LogD: 0.13
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.49Np Likeness Score: -1.30

References

1. Maryamabadi A, Hasaninejad A, Nowrouzi N, Mohebbi G, Asghari B..  (2016)  Application of PEG-400 as a green biodegradable polymeric medium for the catalyst-free synthesis of spiro-dihydropyridines and their use as acetyl and butyrylcholinesterase inhibitors.,  24  (6): [PMID:26879857] [10.1016/j.bmc.2016.02.019]

Source